Biomarkers in Neurodegenerative Diseases 2.0
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (15 February 2022) | Viewed by 47856
Special Issue Editor
Interests: post-transcriptional regulation of gene expression; RNA and protein biochemistry; neurodegenerative and cardiovascular disease mechanisms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases have presented themselves as significant challenges to the quality of life for millions of people worldwide, affecting an increasing number of people. Researchers and healthcare professionals are undertaking substantial efforts to counter such diseases. Some of the effective approaches include endeavors in basic research areas to better understand the disease mechanisms, identify novel biomarkers for early intervention, improved diagnosis, and experimental medicine for better disease management. We are pleased to announce the second volume of the Special Issue “Biomarkers in Neurodegenerative Diseases”, which will highlight the recent advances in this field. We want to welcome original research articles, reviews, and commentaries highlighting emerging strategies for countering these challenges stemming from neurodegenerative diseases in the future.
Dr. Arnab Ghosh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- disease mechanisms
- biomarkers
- disease management
- diagnosis
- experimental medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issues
- Biomarkers in Neurodegenerative Diseases in Biomedicines (12 articles)
- Biomarkers in Neurodegenerative Diseases in Biomedicines (12 articles)